ArticleThe American journal of tropical medicine and hygiene2017
Mucosal leishmaniasis: A Retrospective Study of 327 Cases from an Endemic Area of
Article in The American journal of tropical medicine and hygiene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06550609 (Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine), which is not on this map. Cited by 27 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine
Who cites it
27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.
- The cure rate after different treatments for mucosal leishmaniasis in the Americas: A systematic review.PLoS neglected tropical diseases · 2022Pooled it
- Clinical criteria for Mucosal Leishmaniasis diagnosis in rural South America: A systematic literature review.PLoS neglected tropical diseases · 2022Pooled it
- Safety and efficacy of allylamines in the treatment of cutaneous and mucocutaneous leishmaniasis: A systematic review.PloS one · 2021Pooled it
- A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Trial
- Laryngeal leishmaniasis presenting with hoarseness in a child from the highland of Nepal: A rare diagnostic challenge.IDCases · 2026Article
- Inhaled Pentamidine for Bolivian Mucosal Leishmaniasis.The American journal of tropical medicine and hygiene · 2025Article
- Spatial epidemiologic trends of cutaneous leishmaniasis in Rio de Janeiro State, Southeast Brazil, 2001-2020.Revista do Instituto de Medicina Tropical de Sao Paulo · 2025Article
- Mice mucosal leishmaniasis model shown high parasite load, increased cytotoxicity and impaired IL-10Frontiers in immunology · 2025Article
- Mucosal leishmaniasis is associated with the Leishmania RNA virus and inappropriate cutaneous leishmaniasis treatment.PloS one · 2025Article
- Tongue, larynx and esophageal leishmaniosis in an immunocompetent patient: a case report with description of imaging findings and discussion of current literature: A case of multifocal mucosal leishmaniosis.Radiology case reports · 2024Article
- Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.Emerging infectious diseases · 2024Article
- Senescent T cells: Beneficial and detrimental roles.Immunological reviews · 2023Review
- Mucosal Leishmaniasis of the lip: Report of an Exuberant case in a Young man.Head and neck pathology · 2023Article
- Oral mucosal leishmaniasis presenting as a nonhealing chronic oral growth: A case report.Clinical case reports · 2023Article
- Clinical Diagnosis and Management of Mucosal Leishmaniasis in the Context of a Global Pandemic: A Case Report.Cureus · 2022Article
- Ageing impairs protective immunity and promotes susceptibility to murine visceral leishmaniasis.Parasitology · 2022Article
- Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement.Tropical diseases, travel medicine and vaccines · 2022Article
- Protection and Pathology inPathogens (Basel, Switzerland) · 2022Review
- Treatment of Bolivian Leishmania braziliensis Cutaneous and Mucosal Leishmaniasis.The American journal of tropical medicine and hygiene · 2022Article
- Ros3 (Lem3p/CDC50) Gene Dosage Is Implicated in Miltefosine Susceptibility inACS infectious diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
Mucosal leishmaniasis (ML) is observed only in about 3% of patients with American tegumentary leishmaniasis (ATL) but has a high potential for destructive, disfiguring, and disabling sequelae. Prior reports of clinical and epidemiologic features of ML are limited by small numbers of cases. In this study, we evaluated changes in the demographic features and clinical presentation of ML in an endemic area of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.